产品封面图
文献支持

NuGel-HemogloBind™ (Hemoglobin

Removal) Kit
收藏
  • ¥650
  • 北鱼生物
  • NP-HO-T25
  • 美国
  • 2026年03月03日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 库存

      200

    • 英文名

      NuGel-HemogloBind™ (Hemoglobin Removal) Kit

    • CAS号

      N/a

    • 保质期

      咨询

    • 供应商

      南京北鱼生物科技有限公司

    • 保存条件

      参考COA

    • 规格

      kit

    NuGel-HemogloBind™
    Hemoglobin Removal with NuGel™ Dry-Bead Format
    • Has a high degree of specificity for hemoglobin binding up to 10 mg/ml
    • Species agnostic; including human, mouse, rat, sheep, bovine, goat, etc
    • Removes hemoglobin from clarified organ/tissue lysates.
    • Hemoglobin removal from red blood cell lysate for proteomics and biomarker drug discovery
    • The flow through fractions (hemoglobin depleted) retain their enzymatic and biological activity
    • Compatible with LC-MS, activity-based profiling and proteomic investigations
    • Validated in the automation compatible high-throughput DPX Technologies XTR tip format
    NuGel™ Hemoglobind™ is a modified version of suspension HemogloBind™, engineered for increased stability and improved installation for high-throughput formats. It is based on NuGel™ silica (50 microns in size, 1000Å) covalently bound to elastomeric polyelectrolytes. Comparable to selection properties of suspension HemogloBind™, at recommended quantities, >95% of hemoglobin can be removed with very high selectivity.

    产品细节图片1产品细节图片2产品细节图片3

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献

    5
    05142025
    Selection of NuGel™HemogloBind ™ and related HemogloBind™ References
    Leitner, Dominique F., et al. "Metabolomic, Proteomic, and Transcriptomic Changes in Adults with Epilepsy on Modified Atkins
    Diet." Epilepsia (2023). For Plasma Metabolomics, the article states “Whole blood was thawed on ice and processed to remove
    hemoglobin by NuGel-HemogloBind according to manufacturer protocol…”
    Jara, Zaira Palomino, et al. "Distinct Mechanisms of β-Arrestin–Biased Agonist and Blocker of AT1R in Preventing Aortic Aneurysm
    and Associated Mortality." Hypertension 80.2 (2023): 385-402. The article states “Cleaned abdominal aortas were homogenized in T-
    PER Tissue Protein Extraction reagent…. Abdominal aneurysm samples were treated to remove hemoglobin captured within
    the vessel wall. NuGel-HemogloBind … was used according to the manufacturer protocol.”
    Zhang, X., Li, S., Malik, I. et al. Reprogramming tumour-associated macrophages to outcompete cancer
    cells. Nature (2023). To measure the amino acid content by LC-MS from tumor
    interstitial fluid, the article states “Samples were brought through a NuGel-HemogloBind prep prior to extraction to remedy
    the levels of haemolysis present

    相关实验
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    询价
    富士胶片和光(广州)贸易有限公司
    2025年11月06日询价
    ¥1759.40
    上海瑶韵生物科技有限公司
    2026年03月27日询价
    ¥3821
    北京智杰方远科技有限公司
    2025年07月15日询价
    ¥100
    上海博耀商贸有限公司
    2025年07月10日询价
    ¥749
    苏州瑞诺德生物科技有限公司
    2026年02月05日询价
    文献支持
    NuGel-HemogloBind™ (Hemoglobin Removal) Kit
    ¥650